Development of immunotherapy combination strategies in cancer TA Yap, EE Parkes, W Peng, JT Moyers, MA Curran, HA Tawbi Cancer discovery 11 (6), 1368-1397, 2021 | 243 | 2021 |
Clinical development of AKT inhibitors and associated predictive biomarkers to guide patient treatment in cancer medicine N Coleman, JT Moyers, A Harbery, I Vivanco, TA Yap Pharmacogenomics and personalized medicine, 1517-1535, 2021 | 49 | 2021 |
Association of sociodemographic factors with immunotherapy receipt for metastatic melanoma in the US JT Moyers, A Patel, W Shih, G Nagaraj JAMA network open 3 (9), e2015656-e2015656, 2020 | 45 | 2020 |
The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone JR Mays, SA Hill, JT Moyers, BSJ Blagg Bioorganic & medicinal chemistry 18 (1), 249-266, 2010 | 44 | 2010 |
Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases JT Moyers, EG Chong, J Peng, HHC Tsai, D Sufficool, D Shavlik, ... Cancer Medicine 10 (4), 1201-1211, 2021 | 27 | 2021 |
Analysis of post-transplant lymphoproliferative disorder (PTLD) outcomes with Epstein–Barr virus (EBV) assessments—a single tertiary referral center experience and review of … E Lau, JT Moyers, BC Wang, ISD Jeong, J Lee, L Liu, M Kim, R Villicana, ... Cancers 13 (4), 899, 2021 | 20 | 2021 |
The cure from within? a review of the microbiome and diet in melanoma P Kumar, D Brazel, J DeRogatis, JBG Valerin, K Whiteson, WA Chow, ... Cancer and Metastasis Reviews 41 (2), 261-280, 2022 | 14 | 2022 |
Genomic alterations and tumor mutation burden in Merkel cell carcinoma D Brazel, P Kumar, H Doan, T Pan, W Shen, L Gao, JT Moyers JAMA Network Open 6 (1), e2249674-e2249674, 2023 | 13 | 2023 |
Impact of biomarker-matched therapies on outcomes in patients with sarcoma enrolled in early-phase clinical trials (SAMBA 101) R Carmagnani Pestana, JT Moyers, J Roszik, S Sen, DS Hong, A Naing, ... Clinical Cancer Research 29 (9), 1708-1718, 2023 | 12 | 2023 |
Think globally, act locally: globalizing precision oncology JT Moyers, V Subbiah Cancer discovery 12 (4), 886-888, 2022 | 11 | 2022 |
Development of immunotherapy combination strategies in cancer. Cancer Discov 11: 1368–1397 TA Yap, EE Parkes, W Peng, JT Moyers, MA Curran, HA Tawbi | 9 | 2021 |
Association of Sociodemographic Factors with Immunotherapy Receipt for metastatic melanoma in the US. JAMA Netw Open 3: e2015656 JT Moyers, A Patel, W Shih, G Nagaraj | 8 | 2020 |
Development of Immunotherapy Combination Strategies in Cancer. Cancer Discov (2021) 11: 1368–97. doi: 10.1158/2159-8290 TA Yap, EE Parkes, W Peng, JT Moyers, MA Curran, HA Tawbi CD-20-1209, 0 | 7 | |
Immunotherapy for melanoma JT Moyers, IC Glitza Oliva Immunotherapy, 81-111, 2021 | 6 | 2021 |
A rash in a hairy situation: Leukocytoclastic vasculitis at presentation of hairy cell Leukemia JT Moyers, LW Liu, S Ossowski, L Goddard, MO Kamal, H Cao American Journal of Hematology 94 (12), 1433-1434, 2019 | 6 | 2019 |
Examining stripes on a herd of zebras: Impact of genomic matching for ultrarare sarcomas in phase 1 clinical trials (SAMBA 102) JT Moyers, RC Pestana, J Roszik, DS Hong, A Naing, S Fu, S Piha-Paul, ... Clinical Cancer Research 29 (2), 401-409, 2023 | 5 | 2023 |
Immunotherapy in resected stage III melanoma: An analysis of the National Cancer Database JT Moyers, EG Chong, J Mitchell, A Patel, ISD Jeong, G Nagaraj Cancer Research 80 (16_Supplement), 4338-4338, 2020 | 5 | 2020 |
Thyroid dysfunction from inhibitor of fibroblast growth factor receptor J Ahn, J Moyers, J Wong, CT Hsueh Experimental Hematology & Oncology 8, 1-4, 2019 | 5 | 2019 |
Fatal recurrent disseminated Lomentospora prolificans infection during autologous hematopoietic stem cell transplantation: A case report and review, and … VJ Gow‐Lee, JT Moyers, DK Rogstad Transplant Infectious Disease 23 (6), e13701, 2021 | 4 | 2021 |
Case report: nivolumab-induced autoimmune pancreatitis P Goyal, JT Moyers, BG Elgohary, MB Hammami Journal of Immunotherapy and Precision Oncology 4 (4), 208-211, 2021 | 3 | 2021 |